Skip to main content

Addressing a Public Health Crisis: Applications for COVID-19 Antibody Testing

Description: COVID-19 antibody testing plays a critical role in the public health response to this pandemic, including helping to determine prevalence of SARS-CoV-2 infection in the community or population of interest; providing information to assist in surveillance program efforts, and implement disease mitigation. During this presentation the presenters discuss commercial lab and public health collaborations, including current COVID-19 initiatives, explain the basis for serology tests for COVID-19 and recommendations for use, describe the utility of antibody testing in seroprevalence surveillance, and containment.

 

At the conclusion of this program, participants will be able to: 

  -  Discuss commercial lab and public health collaborations, including

     current COVID-19 initiatives 

  -  Explain the basis for serology tests for COVID-19 and recommendations

     for use 

  -  Describe the utility of antibody testing in seroprevalence surveillance

     and containment

Date:
Jul 27, 2020
Location:

 

  -  Hema Kapoor, MD SM, D(ABMM), Senior Medical Director

     Infectious Diseases & Immunology and Global Diagnostics

     Network, Quest Diagnostics, Secaucus, New Jersey  

 

  -  William A Meyer III,  PhD, D(ABMM), MLS(ASCP)CM, Director,

     Medical Science Liaison, Infectious Diseases/Immunology,

     Technical Director- Quest Diagnostics, East Region Baltimore,

     Maryland  

 

 -  Jay G. Wohlgemuth, M.D., Chief Medical Officer, Senior Vice

    President, Research & Development and Medical, Quest

    Diagnostics, San Juan Capistrano, California